- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 1.32M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $11.94M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $14.18M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.55M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.2M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.66M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.3M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $14.92M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $16.84M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $15.37M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $17.13M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 1.08M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$5.94M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $28.16M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $32.33M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$5.05 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$5.05 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.28M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $2.46M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$5.48M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$5.74M |